Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,389 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bortezomib-resistant nuclear factor-kappaB activity in multiple myeloma cells.
Markovina S, Callander NS, O'Connor SL, Kim J, Werndli JE, Raschko M, Leith CP, Kahl BS, Kim K, Miyamoto S. Markovina S, et al. Among authors: miyamoto s. Mol Cancer Res. 2008 Aug;6(8):1356-64. doi: 10.1158/1541-7786.MCR-08-0108. Mol Cancer Res. 2008. PMID: 18708367 Free PMC article.
Microscale functional cytomics for studying hematologic cancers.
Young EW, Pak C, Kahl BS, Yang DT, Callander NS, Miyamoto S, Beebe DJ. Young EW, et al. Among authors: miyamoto s. Blood. 2012 Mar 8;119(10):e76-85. doi: 10.1182/blood-2011-10-384347. Epub 2012 Jan 18. Blood. 2012. PMID: 22262772 Free PMC article.
TPL2 kinase regulates the inflammatory milieu of the myeloma niche.
Hope C, Ollar SJ, Heninger E, Hebron E, Jensen JL, Kim J, Maroulakou I, Miyamoto S, Leith C, Yang DT, Callander N, Hematti P, Chesi M, Bergsagel PL, Asimakopoulos F. Hope C, et al. Among authors: miyamoto s. Blood. 2014 May 22;123(21):3305-15. doi: 10.1182/blood-2014-02-554071. Epub 2014 Apr 10. Blood. 2014. PMID: 24723682 Free PMC article.
Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network.
Callander N, Markovina S, Eickhoff J, Hutson P, Campbell T, Hematti P, Go R, Hegeman R, Longo W, Williams E, Asimakopoulos F, Miyamoto S. Callander N, et al. Among authors: miyamoto s. Cancer Chemother Pharmacol. 2014 Oct;74(4):875-82. doi: 10.1007/s00280-014-2550-5. Epub 2014 Aug 29. Cancer Chemother Pharmacol. 2014. PMID: 25168296 Free PMC article. Clinical Trial.
Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma.
Jensen JL, Rakhmilevich A, Heninger E, Broman AT, Hope C, Phan F, Miyamoto S, Maroulakou I, Callander N, Hematti P, Chesi M, Bergsagel PL, Sondel P, Asimakopoulos F. Jensen JL, et al. Among authors: miyamoto s. Cancer Immunol Res. 2015 Aug;3(8):881-90. doi: 10.1158/2326-6066.CIR-15-0025-T. Epub 2015 May 4. Cancer Immunol Res. 2015. PMID: 25941352 Free PMC article.
Strategies from UW-Madison for rescuing biomedical research in the US.
Kimble J, Bement WM, Chang Q, Cox BL, Drinkwater NR, Gourse RL, Hoskins AA, Huttenlocher A, Kreeger PK, Lambert PF, Mailick MR, Miyamoto S, Moss RL, O'Connor-Giles KM, Roopra A, Saha K, Seidel HS. Kimble J, et al. Among authors: miyamoto s. Elife. 2015 Jun 30;4:e09305. doi: 10.7554/eLife.09305. Elife. 2015. PMID: 26122792 Free PMC article.
3,389 results